Association of TLR and TREM-1 gene polymorphisms with risk of coronary artery disease in a Russian population

Gene

Volumn 550, Issue 1, 2014, Pages 101-109

  Golovkin, Alexey S ^a   Ponasenko, Anastasia V ^a   Khutornaya, Maria V ^a   Kutikhin, Anton G ^a,b   Salakhov, Ramil R ^a   Yuzhalin, Arseniy E ^c   Zhidkova, Irina I ^a   Barbarash, Olga L ^a   Barbarash, Leonid S ^a  

^a RESEARCH INSTITUTE FOR COMPLEX ISSUES OF CARDIOVASCULAR DISEASES   (Russian Federation)

^b KEMEROVO STATE MEDICAL UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Atherosclerosis; Coronary artery disease; Gene polymorphisms; Immunity; Toll like receptors; Triggering Receptor Expressed on Myeloid Cells 1

Indexed keywords

TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM1 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; RUSSIAN (PEOPLE); SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYNTAX SCORE; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RUSSIAN FEDERATION;

AGED; CORONARY ARTERY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; RUSSIA; TOLL-LIKE RECEPTOR 1;

EID: 84906937777     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.08.022     Document Type: Article

References (59)

1. Ameziane N., Beillat T., Verpillat P., Chollet-Martin S., Aumont M.C., Seknadji P., Lamotte M., Lebret D., Ollivier V., de Prost D. Association of the toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler. Thromb. Vasc. Biol. 2003, 23(12):e61-e64.
2. Balistreri C.R., Candore G., Colonna-Romano G., Lio D., Caruso M., Hoffmann E., Franceschi C., Caruso C. Role of toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 2004, 292(19):2339-2340.
3. Balistreri C.R., Candore G., Mirabile M., Lio D., Caimi G., Incalcaterra E., Caruso M., Hoffmann E., Caruso C. TLR2 and age-related diseases: potential effects of Arg753Gln and Arg677Trp polymorphisms in acute myocardial infarction. Rejuvenation Res. 2008, 11(2):293-296.
4. Benditt E.P., Barrett T., McDougall J.K. Viruses in the etiology of atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:6386-6389.
5. Boekholdt S.M., Agema W.R., Peters R.J., Zwinderman A.H., van der Wall E.E., Reitsma P.H., Kastelein J.J., Jukema J.W. REgression GRowth Evaluation Statin Study Group. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 2003, 107(19):2416-2421.
6. Chen Q., Zhou H., Wu S., Wang H., Lv C., Cheng B., Xie G., Fang X. Lack of association between TREM-1 gene polymorphisms and severe sepsis in a Chinese Han population. Hum. Immunol. 2008, 69(3):220-226.
7. De Staercke C., Lally C., Austin H., Winston C., Dowling N., Williams B., Hooper W.C. The lack of association between four point mutations in the promoter region of the toll-like 4 receptor gene and myocardial infarction. Thromb. Res. 2007, 119(1):105-110.
8. Dower K., Ellis D.K., Saraf K., Jelinsky S.A., Lin L.L. Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide. J. Immunol. 2008, 180(5):3520-3534.
9. Drechsler M., Megens R.T., van Zandvoort M., Weber C., Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 2010, 122(18):1837-1845.
10. Džumhur A., Zibar L., Wagner J., Simundić T., Dembić Z., Barbić J. Association studies of gene polymorphisms in toll-like receptors 2 and 4 in Croatian patients with acute myocardial infarction. Scand. J. Immunol. 2012, 75(5):517-523.
11. Edfeldt K., Bennet A.M., Eriksson P., Frostegård J., Wiman B., Hamsten A., Hansson G.K., de Faire U., Yan Z.Q. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur. Heart J. 2004, 25(16):1447-1453.
12. Enquobahrie D.A., Smith N.L., Bis J.C., Carty C.L., Rice K.M., Lumley T., Hindorff L.A., Lemaitre R.N., Williams M.A., Siscovick D.S., Heckbert S.R., Psaty B.M. Cholesterol ester transfer protein, interleukin-8, peroxisome proliferator activator receptor alpha, and toll-like receptor 4 genetic variations and risk of incident nonfatal myocardial infarction and ischemic stroke. Am. J. Cardiol. 2008, 101(12):1683-1688.
13. Ford J.W., McVicar D.W. TREM and TREM-like receptors in inflammation and disease. Curr. Opin. Immunol. 2009, 21(1):38-46.
14. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu. Rev. Immunol. 2009, 27:165-197.
15. Hansson G.K. Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352(16):1685-1695.
16. Hansson G.K., Robertson A.K., Soderberg-Naucler C. Inflammation and atherosclerosis. Annu. Rev. Pathol. 2006, 1:297-329.
17. Hernesniemi J., Lehtimäki T., Rontu R., Islam M.S., Eklund C., Mikkelsson J., Ilveskoski E., Kajander O., Goebeler S., Viiri L.E., Hurme M., Karhunen P.J. Toll-like receptor 4 polymorphism is associated with coronary stenosis but not with the occurrence of acute or old myocardial infarctions. Scand. J. Clin. Lab. Invest. 2006, 66(8):667-675.
18. Holloway J.W., Yang I.A., Ye S. Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction. Pharmacogenet. Genomics 2005, 15(1):15-21.
19. Incalcaterra E., Caruso M., Balistreri C.R., Candore G., Lo Presti R., Hoffmann E., Caimi G. Role of genetic polymorphisms in myocardial infarction at young age. Clin. Hemorheol. Microcirc. 2010, 46(4):291-298.
20. Jung E.S., Kim S.W., Moon C.M., Shin D.J., Son N.H., Kim E.S., Lee H.J., Hong S.P., Kim T.I., Kim W.H., Cheon J.H. Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and inflammatory bowel diseases in the Korean population. Life Sci. 2011, 89(9-10):289-294.
21. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34(5):637-650.
22. Koch W., Hoppmann P., Pfeufer A., Schömig A., Kastrati A. Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population. Eur. Heart J. 2006, 27(21):2524-2529.
23. Kutikhin A.G. Impact of toll-like receptor 4 polymorphisms on risk of cancer. Hum. Immunol. 2011, 72(2):193-206.
24. Kutikhin A.G., Yuzhalin A.E. Inherited variation in pattern recognition receptors and cancer: dangerous liaisons?. Cancer Manag. Res. 2012, 4:31-38.
25. Lalouschek W., Schillinger M., Hsieh K., Endler G., Greisenegger S., Marculescu R., Lang W., Wagner O., Cheng S., Mannhalter C. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin. Chem. Lab. Med. 2006, 44(8):918-923.
26. Lamba V., Lamba J., Yasuda K., et al. Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J. Pharmacol. Exp. Ther. 2003, 307(3):906-922.
27. Libby P. Inflammation in atherosclerosis. Nature 2002, 420(6917):868-874.
28. Lima-Neto L.G., Hirata R.D., Luchessi A.D., Silbiger V.N., Pastorelli C.P., Sampaio M.F., Armaganijan D., Rezende A.A., Doi S.Q., Hirata M.H. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays. Genet. Test. Mol. Biomarkers 2009, 13(3):343-347.
29. Lima-Neto L.G., Hirata R.D., Luchessi A.D., Silbiger V.N., Stephano M.A., Sampaio M.F., Armaganijan D., Hirata M.H. CD14 and IL6 polymorphisms are associated with a pro-atherogenic profile in young adults with acute myocardial infarction. J. Thromb. Thrombolysis 2013, 36(3):332-340.
30. Lin Y.C., Chang Y.M., Yu J.M., Yen J.H., Chang J.G., Hu C.J. Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan. Atherosclerosis 2005, 180(2):305-309.
31. Manthey H.D., Zernecke A. Dendritic cells in atherosclerosis: functions in immune regulation and beyond. Thromb. Haemost. 2011, 106(5):772-778.
32. Molloy E.J. Triggering Receptor Expressed on Myeloid Cells (TREM) family and the application of its antagonists. Recent Pat. Antiinfect. Drug Discov. 2009, 4(1):51-56.
33. Morange P.E., Tiret L., Saut N., Luc G., Arveiler D., Ferrieres J., Amouyel P., Evans A., Ducimetiere P., Cambien F., Juhan-Vague I., PRIME Study Group TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: the PRIME study. Eur. J. Hum. Genet. 2004, 12(12):1041-1049.
34. Nathan C., Ding A. TREM-1: a new regulator of innate immunity in sepsis syndrome. Nat. Med. 2001, 7(5):530-532.
35. Nebel A., Flachsbart F., Schäfer A., Nothnagel M., Nikolaus S., Mokhtari N.E., Schreiber S. Role of the toll-like receptor 4 polymorphism Asp299Gly in longevity and myocardial infarction in German men. Mech. Ageing Dev. 2007, 128(5-6):409-411.
36. Norata G.D., Garlaschelli K., Ongari M., Raselli S., Grigore L., Benvenuto F., Maggi F.M., Catapano A.L. Effect of the toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J. Intern. Med. 2005, 258(1):21-27.
37. Park H.J., Kim S.K., Yun D.H., Kim D.H., Chon J., Kim J.W., Chung J.H. Association of toll-like receptor 2 polymorphisms with National Institute of Health Stroke Scale scores of ischemic stroke patients. J. Mol. Neurosci. 2012, 46(3):536-540.
38. Reismann P., Lichy C., Rudofsky G., Humpert P.M., Genius J., Si T.D., Dörfer C., Grau A.J., Hamann A., Hacke W., Nawroth P.P., Bierhaus A. Lack of association between polymorphisms of the toll-like receptor 4 gene and cerebral ischemia. J. Neurol. 2004, 251(7):853-858.
39. Rivera-Chávez F.A., Huebinger R.M., Burris A., Liu M.M., Minei J.P., Hunt J.L., Arnoldo B.D., Barber R.C. A TREM-1 polymorphism A/T within the exon 2 is associated with pneumonia in burn-injured patients. ISRN Inflamm. 2013, 2013:431739.
40. Rosenfeld M.E., Campbell L.A. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb. Haemost. 2011, 106(5):858-867.
41. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362(6423):801-809.
42. Sianos G., Morel M.A., Kappetein A.P., Morice M.C., Colombo A., Dawkins K., van den Brand M., Van Dyck N., Russell M.E., Mohr F.W., Serruys P.W. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005, 1(2):219-227.
43. Solé X., Guinó E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22(15):1928-1929.
44. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat. Med. 2002, 8(11):1211-1217.
45. Su L., Liu C., Li C., Jiang Z., Xiao K., Zhang X., Li M., Yan P., Feng D., Xie L. Dynamic changes in serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and its gene polymorphisms are associated with sepsis prognosis. Inflammation 2012, 35(6):1833-1843.
46. Thomas K.H., Meyn P., Suttorp N. Single nucleotide polymorphism in 5'-flanking region reduces transcription of surfactant protein B gene in H441 cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291(3):L386-L390.
47. Tierney M.J., Medcalf R.L. Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs. J. Biol. Chem. 2001, 276(17):13675-13684.
48. Tiszlavicz Z., Somogyvári F., Kocsis A.K., Szolnoki Z., Sztriha L.K., Kis Z., Vécsei L., Mándi Y. Relevance of the genetic polymorphism of NOD1 in Chlamydia pneumoniae seropositive stroke patients. Eur. J. Neurol. 2009, 16(11):1224-1229.
49. Vallejo J.G. Role of toll-like receptors in cardiovascular diseases. Clin. Sci. (Lond.) 2011, 121(1):1-10.
50. Valtonen V.V. Infection as a risk factor for infarction and atherosclerosis. Ann. Med. 1991, 23(5):539-543.
51. Weber C., Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 2011, 17(11):1410-1422.
52. Weber C., Zernecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 2008, 8(10):802-815.
53. Weber C., Meiler S., Döring Y., Koch M., Drechsler M., Megens R.T., et al. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J. Clin. Invest. 2011, 121(7):2898-2910.
54. Xu Q., Willeit J., Marosi M., Kleindienst R., Oberhollenzer F., Kiechl S., Stulnig T., Luef G., Wick G. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 1993, 341(8840):255-259.
55. Yang S.A. Association of TLR6 single nucleotide polymorphisms and clinical features of ischemic stroke in Korean population. J. Exerc. Rehabil. 2013, 9(6):526-531.
56. Yin Y.W., Sun Q.Q., Hu A.M., Liu H.L., Wang Q., Zhang B.B. Toll-like receptor 4 gene Asp299Gly polymorphism in myocardial infarction: a meta-analysis of 15,148 subjects. Hum. Immunol. 2014, 75(2):163-169.
57. Zee R.Y., Hegener H.H., Gould J., Ridker P.M. Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis. Stroke 2005, 36(1):154-157.
58. Zernecke A., Bot I., Djalali-Talab Y., Shagdarsuren E., Bidzhekov K., Meiler S., et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ. Res. 2008, 102(2):209-217.
59. Zysow B.R., Lindahl G.E., Wade D.P., Knight B.L., Lawn R.M. C/T polymorphism in the 5' untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler. Thromb. Vasc. Biol. 1995, 15(1):58-64.